UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan
· Delayed Price · Currency is TWD 65.50
+0.10 (0.15%)
May 9, 2025, 1:15 PM CST
UnicoCell Biomed Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 9.57 | 19.9 | 53.64 | 130.85 | 222.02 | Upgrade
|
| Short-Term Investments | 518.37 | 457.38 | 160.25 | 10.17 | 10.09 | Upgrade
|
| Trading Asset Securities | 22.3 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 550.24 | 477.28 | 213.89 | 141.02 | 232.11 | Upgrade
|
| Cash Growth | 15.29% | 123.15% | 51.67% | -39.24% | 1.40% | Upgrade
|
| Accounts Receivable | 2.81 | 2.08 | 1.38 | 0.4 | 0.75 | Upgrade
|
| Other Receivables | 19.6 | 18.08 | 13.47 | 12.02 | 0.11 | Upgrade
|
| Receivables | 22.41 | 20.16 | 14.84 | 12.42 | 0.87 | Upgrade
|
| Inventory | 9.75 | 7.5 | 7.98 | 7.83 | 4.01 | Upgrade
|
| Prepaid Expenses | 3.66 | 1.61 | 1.13 | 2.04 | 14.41 | Upgrade
|
| Other Current Assets | 6.29 | 0.24 | 0.06 | - | 0 | Upgrade
|
| Total Current Assets | 592.35 | 506.8 | 237.9 | 163.31 | 251.4 | Upgrade
|
| Property, Plant & Equipment | 152.59 | 175.89 | 173.36 | 131.21 | 132.35 | Upgrade
|
| Long-Term Investments | 29 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 0.34 | 0.33 | 0.36 | 0.4 | 0.78 | Upgrade
|
| Other Long-Term Assets | 3.61 | 2.92 | 2.7 | 2.8 | 6.7 | Upgrade
|
| Total Assets | 777.89 | 685.93 | 414.31 | 297.71 | 391.22 | Upgrade
|
| Accounts Payable | 1.97 | 0.11 | 0.91 | 0.08 | 0.51 | Upgrade
|
| Current Portion of Leases | 6.22 | 6.09 | 5.93 | 8.95 | 10.11 | Upgrade
|
| Current Unearned Revenue | 6.62 | 0.02 | 1.52 | - | - | Upgrade
|
| Other Current Liabilities | 12.32 | 10.68 | 8.18 | 12.34 | 12.6 | Upgrade
|
| Total Current Liabilities | 27.13 | 16.9 | 16.54 | 21.37 | 23.22 | Upgrade
|
| Long-Term Leases | 62.02 | 68.24 | 60.66 | 12.63 | 23.88 | Upgrade
|
| Other Long-Term Liabilities | 4.13 | 4.35 | 3.26 | 0.71 | 0.71 | Upgrade
|
| Total Liabilities | 93.28 | 89.49 | 80.46 | 34.71 | 47.81 | Upgrade
|
| Common Stock | 584.11 | 556.85 | 423.61 | 377.75 | 375.7 | Upgrade
|
| Additional Paid-In Capital | 705.87 | 551.89 | 338.43 | 222.29 | 218.37 | Upgrade
|
| Retained Earnings | -605.37 | -512.29 | -428.19 | -337.03 | -250.66 | Upgrade
|
| Shareholders' Equity | 684.61 | 596.44 | 333.85 | 263.01 | 343.41 | Upgrade
|
| Total Liabilities & Equity | 777.89 | 685.93 | 414.31 | 297.71 | 391.22 | Upgrade
|
| Total Debt | 68.24 | 74.33 | 66.59 | 21.58 | 33.99 | Upgrade
|
| Net Cash (Debt) | 482.01 | 402.95 | 147.3 | 119.44 | 198.12 | Upgrade
|
| Net Cash Growth | 19.62% | 173.56% | 23.32% | -39.71% | 7.53% | Upgrade
|
| Net Cash Per Share | 8.40 | 7.49 | 3.55 | 3.17 | 5.58 | Upgrade
|
| Filing Date Shares Outstanding | 58.41 | 55.69 | 42.36 | 37.78 | 37.57 | Upgrade
|
| Total Common Shares Outstanding | 58.41 | 55.69 | 42.36 | 37.78 | 37.57 | Upgrade
|
| Working Capital | 565.22 | 489.9 | 221.36 | 141.94 | 228.18 | Upgrade
|
| Book Value Per Share | 11.72 | 10.71 | 7.88 | 6.96 | 9.14 | Upgrade
|
| Tangible Book Value | 684.27 | 596.12 | 333.5 | 262.61 | 342.63 | Upgrade
|
| Tangible Book Value Per Share | 11.71 | 10.71 | 7.87 | 6.95 | 9.12 | Upgrade
|
| Machinery | 70 | 67.02 | 65.56 | 60.92 | 49.91 | Upgrade
|
| Construction In Progress | - | - | - | 68.3 | 52.22 | Upgrade
|
| Leasehold Improvements | 98.28 | 97.5 | 93.25 | 16.35 | 16.35 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.